The<unk>  (GPELF) is a World Health Organization project to eradicate the Filarioidea worms which cause the disease<unk><unk>  and also treat the people who already have the infection. The GPELF is a partnership organization in which countries establish a national LF<unk> on program, various international sponsors fund the programs, regional pharmaceutical companies produce medicine, universities assist with monitoring, and the WHO convenes international conversation. A study examined the first 8 years of the organization's programs and reported that they were generally successful and that the<unk> on plan was a good investment for participating countries. A study review 13 years into the program found that the programs were reducing the disease, but not as quickly as planned, and that there would need to be changes to meet the goal of<unk> ng the disease by 2020. As an<unk> on strategy, the organization recommends mass drug administration to at least 65% of the population in areas with an infection rate of 1% or more. China participated in the program and became LF free in 2007.
Global Programme to Eliminate Lymphatic Filariasis
Birth control in Africa
Global Alliance for Rabies Control
Global Research Collaboration for Infectious Disease Preparedness
London Declaration on Neglected Tropical Diseases
Australian Vaccination-risks Network
Vaccines for Children Program
Medicines for Malaria Venture